Near-Normoglycemia and Insulin Regression Induced by Tirzepatide in Basal Insulin-Treated Type 2 Diabetes

被引：0
|
作者：
Rosenstock, Julio
Tofe, Santiago
Wysham, Carol H.
Thieu, Vivian
Kiljanski, Jacek I.
Lee, Clare
Wang, Hui
Patel, Hiren
机构：
来源：
DIABETES | 2024年 / 73卷
关键词：
D O I：
10.2337/db24-757-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
757-P
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Near-normoglycaemia and insulin regression induced by tirzepatide in basal insulin-treated type 2 diabetes
    Patel, H.
    Tofe, S.
    Wysham, C.
    Thieu, V. T.
    Kiljanski, J.
    Lee, C.
    Wang, H.
    Rosenstock, J.
    DIABETOLOGIA, 2024, 67 : S361 - S361
  • [2] Clinical Factors Associated with Insulin Regression When Adding Tirzepatide in Basal Insulin-Treated Type 2 Diabetes
    Wysham, Carol H.
    Rosenstock, Julio
    Tofe, Santiago
    Thieu, Vivian
    Kiljanski, Jacek I.
    Lee, Clare
    Wang, Hui
    Patel, Hiren
    DIABETES, 2024, 73
  • [3] Near-Normoglycemia, with Meaningful Discontinuations of Prandial Insulin, by Adding Weekly Albiglutide (Albi) to Uncontrolled Basal/Bolus Insulin-Treated Type 2 Diabetes (T2DM)
    Rosenstock, Julio
    Nino, Antonio J.
    Soffer, Joseph
    Mallory, Jason M.
    Erskine, Lois M.
    Acusta, Andre
    Dole, Jo F.
    Carr, Molly
    Home, Philip
    DIABETES, 2018, 67
  • [4] "Surpass(ing)" an era of basal-bolus insulin therapy: tirzepatide vs insulin lispro tid added-on to poorly controlled basal insulin-treated type 2 diabetes
    Frias, J. P.
    Rosenstock, J.
    Rodbard, H. W.
    Tofe, S.
    Sears, E.
    Huh, R.
    Lando, L. Fernandez
    Patel, H.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S5 - S6
  • [5] "SURPASS(ing)" an Era of Basal-Bolus Insulin Therapy-Tirzepatide vs. Insulin Lispro TID Added-on to Poorly Controlled Basal Insulin-Treated in Type 2 Diabetes
    Rosenstock, Julio
    Frias, Juan P.
    Rodbard, Helena W.
    Tofe, Santiago
    Sears, Emmalee J.
    Huh, Ruth
    Lando, Laura Fernandez
    Patel, Hiren
    DIABETES, 2023, 72
  • [6] Severe hypoglycaemia in insulin-treated Type 2 diabetes
    Geddes, J.
    Frier, B. M.
    DIABETIC MEDICINE, 2007, 24 (03) : 327 - 327
  • [7] Assessment of basal insulin requirement using fasting tests in insulin-treated patients with type 2 diabetes mellitus
    Wiesli, P.
    Lehmann, R.
    Krayenbuehl, P-A.
    Schmid, C.
    Spinas, G. A.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2006, 114 (10) : 539 - 543
  • [8] Adherence to treatment in insulin-treated type 2 diabetes
    Donnelly, L
    Wang, JX
    Evans, J
    Van Der Velde, J
    Morris, A
    DIABETES, 2002, 51 : A436 - A437
  • [9] Near-normoglycaemia, with meaningful discontinuations of prandial insulin, by adding weekly albiglutide to uncontrolled basal/bolus insulin-treated type 2 diabetes
    Rosenstock, J.
    Nino, A.
    Soffer, J.
    Mallory, J.
    Erskine, L.
    Acusta, A.
    Dole, J.
    Carr, M. C.
    Home, P.
    DIABETOLOGIA, 2018, 61 : S22 - S22
  • [10] BOTH ACUTE AND CHRONIC NEAR-NORMOGLYCEMIA ARE REQUIRED TO IMPROVE INSULIN RESISTANCE IN TYPE-1 (INSULIN-DEPENDENT) DIABETES-MELLITUS
    FASCHING, P
    RATHEISER, K
    DAMJANCIC, P
    SCHNEIDER, B
    NOWOTNY, P
    VIERHAPPER, H
    WALDHAUSL, W
    DIABETOLOGIA, 1993, 36 (04) : 346 - 351
12345